Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 13/20 | 0.50 |
| ▸ | CHRNB4 | P30926 | 13/20 | 0.50 |
| ▸ | CHRNA3 | P32297 | 13/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 13/20 | 0.50 |
| ▸ | XDH | P47989 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL654454 | 0.86 | CHRNB2 (0.35) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL652867 | 0.83 | CHRNB2 (0.33) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| Hydrochloric Acid SCHEMBL653101 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL649861 | 0.82 | CHRNB2 (0.33) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL653686 | 0.81 | CHRNB2 (0.47) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL652499 | 0.81 | CHRNB2 (0.35) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL650035 | 0.79 | CHRNB2 (0.44) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL650738 | 0.79 | CHRNB2 (0.44) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL651979 | 0.79 | CHRNB2 (0.46) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL653607 | 0.79 | CHRNB2 (0.46) | CHRNB2CHRNB4CHRNA3CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119635-B2 | Diazabicyclic central nervous system active agents | ABBOTT LABORATORIES (US) | 2012-02-21 | — | — | US | disclosed |
| EP-2295437-A1 | Diazabicyclic central nervous system active agents | Abbott Laboratories (US) | 2011-03-16 | — | — | EP | disclosed |